My name is Mia Langbøl, PhD. I have a master's in Biochemistry with a specialization in Molecular Cell Biology from the University of Copenhagen (MSc, 2018). My research focuses on the neurodegenerative disease glaucoma, a growing burden due to an aging population. Our hypothesis is that glaucoma could be a systemic disease manifesting in the eye because of the high demand for nutrients and oxygen in the retina. We utilize a human experimental model with hypoxia to stress the vascular and metabolic system of our studied patients with normal-tension glaucoma and ocular hypertension, as well as healthy controls. From plasma, we analyze the status of oxidative stress, inflammation, and metabolism. Our aim is to discover molecular targets that may serve as novel treatments for glaucoma in the future or biomarkers for early detection.
My name is Mia Langbøl, PhD. I have a master's in Biochemistry with a specialization in Molecular Cell Biology from the University of Copenhagen (MSc, 2018). My research focuses on the neurodegenerative disease glaucoma, a growing burden due to an aging population. Our hypothesis is that glaucoma could be a systemic disease manifesting in the eye because of the high demand for nutrients and oxygen in the retina. We utilize a human experimental model with hypoxia to stress the vascular and metabolic system of our studied patients with normal-tension glaucoma and ocular hypertension, as well as healthy controls. From plasma, we analyze the status of oxidative stress, inflammation, and metabolism. Our aim is to discover molecular targets that may serve as novel treatments for glaucoma in the future or biomarkers for early detection.